Events
If you are headed to BioCentury Inc.'s BioEquity Europe Conference and are interested in learning how ImmunoScape is working toward the development of TCR-based...
Next-gen TCR-based therapies against solid tumors have the power to disrupt and transform the development, delivery, and efficacy for cancer patients. Dan Macleod,...
SAN DIEGO & SINGAPORE--(BUSINESS WIRE)--ImmunoScape, a biotechnology company focused on next-generation T Cell receptor (TCR)-based immunotherapies, today announced...
ImmunoScape Leadership to Present at Upcoming Industry Conferences CEO Choon-Peng Ng and Vice President of Innovation, Michael Fehlings, Ph.D., will discuss Asia’s role...
The ImmunoScape team is heading to the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco in a few weeks. Our CEO Choon-Peng (Choon) Ng, our Vice President,...
Florian Schmidt, PhD will be presenting at the upcoming ISMB/ECCB 2023 conference in Lyon. On Thursday, July 27th Florian will describe ImmunoScape’s machine learning...